Geron Return On Equity from 2010 to 2024

GERN Stock  USD 4.12  0.05  1.20%   
Geron Return On Equity yearly trend continues to be very stable with very little volatility. Return On Equity is likely to drop to -0.78. Return On Equity is a measure of the profitability of Geron in relation to the equity, calculated by dividing net income by shareholder's equity. View All Fundamentals
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(0.74)
Current Value
(0.78)
Quarterly Volatility
0.42846184
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Geron financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Geron's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 8.7 M or Selling General Administrative of 72.6 M, as well as many indicators such as Price To Sales Ratio of 5.3 K, Dividend Yield of 0.0 or PTB Ratio of 2.86. Geron financial statements analysis is a perfect complement when working with Geron Valuation or Volatility modules.
  
Check out the analysis of Geron Correlation against competitors.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.

Latest Geron's Return On Equity Growth Pattern

Below is the plot of the Return On Equity of Geron over the last few years. Return on Equity is the amount of Geron net income returned as a percentage of Geron equity. Return on equity measures Geron profitability by revealing how much profit Geron generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Geron's Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Geron's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported -0.6910 Years Trend
Slightly volatile
   Return On Equity   
       Timeline  

Geron Return On Equity Regression Statistics

Arithmetic Mean(0.57)
Geometric Mean0.31
Coefficient Of Variation(75.03)
Mean Deviation0.31
Median(0.47)
Standard Deviation0.43
Sample Variance0.18
Range1.7633
R-Value(0.37)
Mean Square Error0.17
R-Squared0.14
Significance0.17
Slope(0.04)
Total Sum of Squares2.57

Geron Return On Equity History

2024 -0.78
2023 -0.74
2022 -1.76
2021 -0.96
2020 -0.36
2019 -0.47
2018 -0.15

About Geron Financial Statements

Geron investors utilize fundamental indicators, such as Return On Equity, to predict how Geron Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Return On Equity(0.74)(0.78)

Pair Trading with Geron

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Geron position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Geron will appreciate offsetting losses from the drop in the long position's value.

Moving against Geron Stock

  0.73BMY Bristol Myers Squibb Sell-off TrendPairCorr
  0.67ESPR Esperion Therapeutics Buyout TrendPairCorr
  0.6EWTX Edgewise TherapeuticsPairCorr
  0.59GILD Gilead SciencesPairCorr
  0.51EBS Emergent BiosolutionsPairCorr
The ability to find closely correlated positions to Geron could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Geron when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Geron - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Geron to buy it.
The correlation of Geron is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Geron moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Geron moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Geron can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Geron offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Geron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Geron Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Geron Stock:
Check out the analysis of Geron Correlation against competitors.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.32)
Revenue Per Share
0.047
Quarterly Revenue Growth
171.384
Return On Assets
(0.30)
Return On Equity
(0.69)
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.